Opioids have a rapid transplacental passage (ie, less than 60 min); furthermore, symptoms
characterize the maternal and fetal withdrawal syndrome. Opioid withdrawal significantly …

Neonatal abstinence syndrome (NAS) is a growing problem in the United States, related to
increased maternal substance use and abuse, and a set of drug withdrawal symptoms that …

Background Both, maternal borderline personality disorder (BPD) and maternal major
depressive disorder (MDD) are often associated with adverse consequences for children …

Parental opioid use is affecting the physical, developmental, and mental health of the
pediatric population nationwide and raises questions of safety when these children remain …

Objective To explore care experiences of women who used prescription or illicit opioids and
experienced fetal or infant loss. Design A qualitative, descriptive design with secondary data …

Background: Increasing rates of opioid use in the United States have created a national
public health crisis. Substance use in pregnancy increases risk for poor birth outcomes …

This review focuses on drug use during pregnancy and the perinatal period, a constellation
that is seen more often. Drug use in pregnant women poses an increased risk for adverse …

Parental substance misuse and mental health issues are major factors associated with infant
placement into out-of-home care. Such placements may result in disruption and/or cessation …

Introduction: Drug use during pregnancy is a rapidly growing and worrying global problem,
leading to increasing rates of maternal and neonatal mortality and diseases. Pregnant …

Short half-life benzodiazepines like midazolam are used as premedication to relieve intra-
partum pain, and are known to have no adverse effects to the newborn. However, such short …